KIR2DL2 Blocking peptide (C terminal region)

KIR2DL2 Blocking peptide (C terminal region)
SKU
AVIAAP80369-100
Packaging Unit
100µg
Manufacturer
Aviva Systems Biology

Availability: loading...
Price is loading...
Description of Target: Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several "framework" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response.

Product Format: Lyophilized powder

Protein Size: 348
More Information
SKU AVIAAP80369-100
Manufacturer Aviva Systems Biology
Manufacturer SKU AAP80369-100UG
Green Labware No
Package Unit 100µg
Quantity Unit STK
Application Western Blotting
Human Gene ID 3803
Product information (PDF)
×
MSDS (PDF)
×